2018 annual financial data

Neuphoria Therapeutics 2018 Operating cash flow

Direct answer

Operating cash flow was -15.02M USD.

Operating income was -21.28M USD and net income was -18.43M USD.
Operating cash flow was -15.02M USD.

Get free Neuphoria Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
11.94M USD
Operating income
-21.28M USD
Net income
-18.43M USD
Operating cash flow
-15.02M USD